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Mesenchymal–epithelial signalingSpatio-temporal regulation of the balance between cell renewal and cell differentiation is of vital importance
for embryonic development and adult homeostasis. Fibroblast growth factor signaling relayed from the
mesenchyme to the epithelium is necessary for progenitor maintenance during organogenesis of most
endoderm-derived organs, but it is still ambiguous whether the signal is exclusively mitogenic. Furthermore,
the downstream mechanisms are largely unknown. In order to elucidate these questions we performed a
complementary analysis of ﬁbroblast growth factor 10 (Fg f10), gain-of-function and loss-of-function in the
embryonic mouse duodenum, where the progenitor niche is clearly deﬁned and differentiation proceeds in a
spatially organized manner. In agreement with a role in progenitor maintenance, FGF10 is expressed in the
duodenal mesenchyme during early development while the cognate receptor FGFR2b is expressed in the
epithelial progenitor niche. Fg f10 gain-of-function in the epithelium leads to spatial expansion of the
progenitor niche and repression of cell differentiation, while loss-of-function results in premature cell
differentiation and subsequent epithelial hypoplasia. We conclude that FGF10 mediated mesenchymal-to-
epithelial signaling maintains the progenitor niche in the embryonic duodenum primarily by repressing cell
differentiation, rather than through mitogenic signaling. Furthermore, we demonstrate that FGF10-signaling
targets include ETS-family transcription factors, which have previously been shown to regulate epithelial
maturation and tumor progression.ersity Stem Cell Center, BMC
abjerke@virginia.edu
ux@ccf.org (X. Qu),
ensen).
l rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
Organogenesis is a fascinating developmental process involving a
series of integrated events leading to the fully functional organ.
Expansion of the committed progenitor cell population is an early
event in organogenesis. This phase has received increasing attention
during the past few years, due to the promising prospect of stem cell
therapy, which has led to a need for knowledge on how to expand
progenitor cells as a source for replacement therapy for multiple
diseases. Likewise, balancing of progenitor cell expansion and
differentiation features prominently in adult homeostasis of renew-
able organs, such as the intestine, and in themutated state, also during
cancer progression.
It is well known that reciprocal signaling between the epithelium
and the surrounding mesenchyme via soluble and/or membrane-
tethered signals is necessary for regulating growth and differentiation
of the gut epithelium (Haffen et al., 1987;Kedinger et al., 1987), andseveral signaling pathways, includingWNT (Korinek et al., 1998;Pinto
et al., 2003), BMP (He et al., 2004), Notch (Fre et al., 2005;Jensen et al.,
2000;van Es et al., 2005;Wong et al., 2004), and Hedgehog (Madison
et al., 2005;Ramalho-Santos et al., 2000) have been implicated in
regulating gastric and enteric development. Members of the ﬁbroblast
growth factor (FGF) family are mediators of mesenchymal-to-
epithelial signaling in several organs, and are included as a component
in many stem cell differentiation protocols. FGF10 in particular, has
been shown to be necessary for progenitor maintenance during
organogenesis of endoderm-derived organs, but it is still ambiguous
whether the signal is exclusively mitogenic, or whether it also
regulates cell differentiation. Furthermore, the downstream mecha-
nisms are largely unknown.
Fgf10 is expressed in the mesenchyme of the embryonic duodenum
(Bhushanet al., 2001;Kanard et al., 2005;Nyenget al., 2007), aswell as in
the mesenchyme of the lung, stomach, pancreas, colon, and cecum
(Bellusci et al., 1997;Burns et al., 2004;Fairbanks et al., 2004;Nyenget al.,
2007;Sala et al., 2006). Loss-of-functionmutation of Fgf10 or its cognate
receptor Fgfr2b results in lung agenesis (Arman et al., 1999;Sekine et al.,
1999), and severely affects the development of the glandular stomach
(Spencer-Dene et al., 2006) and the pancreas (Bhushan et al., 2001;
Pulkkinen et al., 2003). In the intestines, loss of Fgf10 has been analyzed
thoroughly in the colon (Sala et al., 2006) and the cecum (Burns et al.,
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colonic atresia and failure of cecal budding. Studies of clinical relevance
have implicated Fgf10 in intestinal pathobiology, as Fgf10−/− mice
have duodenal (Kanard et al., 2005) and colonic (Fairbanks et al., 2005)
atresia. Unfortunately, the duodenal phenotype was not analyzed
further. So far, clinical studies have however failed to identify any
association of mutations in Fgf10 and duodenal atresia or anorectal
malformations (Kruger et al., 2008;Tatekawa et al., 2007). The severe
phenotype of loss of Fgf10 prompted an analysis of Fgf10 gain-of-
function in order to understand the mechanism in more detail. Our
studies of the stomach and pancreas have demonstrated that ectopic
Fgf10 overexpression in the epithelium results in inhibition of cell
differentiation (Norgaard et al., 2003;Nyeng et al., 2007), a result that
was corroborated by Hart et al in the pancreas (Hart et al., 2003). Quite
likely, a central function of FGF-signaling in enteric progenitor
maintenance has been overlooked, as previous studies focused mostly
on the time after terminal differentiation.We therefore decided to study
whether ectopic expression of Fgf10 in the duodenal epithelium,
disrupting the endogenous FGF10 gradient emanating from the
mesenchyme, would suppress differentiation outside the progenitor
niche, leading to an expansion of the niche. Reciprocally, we wished to
test whether loss of Fgf10 in the duodenum is sufﬁcient to release
progenitor cells and cause premature differentiation.
In the present work, we demonstrate that FGF10 mediated
mesenchymal-to-epithelial signaling maintains the progenitor
niche in the embryonic small intestine by repressing differentiation.
Furthermore, we demonstrate that FGF10-signaling targets in the
intestine include ETS-family transcription factors Etv4 and Etv5.
Materials and methods
Mouse derivation
Generation of a pPdx1-Fgf10FLAG construct and derivation of
transgenic mouse (Mus musculus) embryos, as described earlier
(Norgaard et al., 2003), were approved by the UCHSC Animal Care and
Use Committee. A total of 3 embryonic day 12.5 (E12.5) and 6 E18.5
pPdx1-Fgf10FLAG embryos and their wildtype (WT) littermates were
obtained by oocyte injection using FVB mice. The day of oocyte transfer
was counted as embryonic day 0.5 (E0.5). BrdU (20mg/kg)was injected
2 h prior to isolation of embryos. Targeted disruption of Fgf10 has
already been described (Min et al., 1998). A total of 8 E14.5 and 8 E18.5
Fgf10−/− embryos were obtained by timed mating of heterozygotes
which had been outbred on a CD1 background. The day of vaginal plug
was counted as E0.5. Heterozygotic littermates were used as controls
throughout, as they were indistinguishable from wildtype embryos.
All embryos were genotyped by PCR. pPdx1-Fg f10FLAG embryos
were genotyped using Fg f10-Flag primers (Table S1) and Fgf10−/−
embryos were genotyped using Fg f10 KO P1, P2, P3 and P4 primers as
described (Sekine et al., 1999). Expression of the pPdx1-Fgf10FLAG
construct was conﬁrmed by RT-PCR of three E18.5 embryos and WT
littermates. pPdx1-Fg f10FLAG embryos varied somewhat in their
expression of the transgene, but although phenotypes were not
identical, theywere highly similar, and the phenotypic variation never
exceeded that observed in Fg f10−/− mice.
Tissue and RNA isolation
Whole guts were dissected in ice-cold PBS and ﬁxed in 4% PFA
overnight. They were then immersed in 30% sucrose for at least 4 h, in
1:1 30% sucrose and OCT embedding medium for 1 h and ﬁnally in OCT
for 1 h before embedding. Tissue blocks were freeze sectioned at a
thickness of 6 μm using a cryotome. Embryos for RNA analysis were
dissected in ice-cold PBS and the upper half of the duodenum including
mesenchyme and epitheliumwas extracted using the RNeasy (Qiagen)
kit including a DNAse treatment step. Endogenous Fgf expression wasanalyzed using RNA from embryos from time-mated CD1 mice. RNA
from E12.5 whole small intestine was pooled from 5 embryos for each
sample. Whole duodenal tissue was pooled from 4 E14.5 embryos, 3
E15.5 embryos or 2 embryos for each of the samples at E16.5, E17.5 and
E18.5. At least three samples were analyzed per time point.
Multiplex RT-PCR analysis
Puriﬁed total RNA was analyzed by a semi-quantitative low-cycle
radioactive multiplex RT-PCR (MPX-RT-PCR) method previously de-
scribed (Jensen et al., 1996) with 2 μg of total RNA per sample. A primer
set for the TATA boxbinding protein (Tbp) or Alpha-tubulin (α-tubulin)
was included in all reactions as an internal control and used for
standardization. Primers (Supplementary Material Table S1) were
speciﬁcally designed for MPX-RT-PCR, optimized for exponential
ampliﬁcation within the cycle range and tested for interference. Six
primerswere included in each reaction and the reactionwas carried out
at 96 °C for 1 min, followed by 28 cycles of 96 °C for 30 s, 55 °C for 30 s
and73 °C for 30 s. Following theRT-PCR reaction, sampleswere runona
denaturing sequencing gel. The gel was subsequently exposed to
phosphoimage storage screen for 3 days, after which the screen was
scanned. Experiments were carried out in triplicate for each sample and
values are expressed as mean±SEM relative to Tbp or α-tubulin.
Immunohistochemistry
Immunohistochemistry (IHC) was carried out as already described
(Norgaard et al., 2003). Primary antibodies are included in Table S1.
0.1% Triton X-100 was added to the blocking buffer. After overnight
incubation with the primary antibodies, slides were washed and
incubated with rabbit/goat/rat/mouse/guinea pig secondary antibody
conjugated to Texas red/Cy2/AMCA (Jackson ImmunoResearch, PA,
USA) for 1 h or taken through the Histostain kit protocol (Zymed/
Invitrogen, CA, USA), followed by tyramide signal ampliﬁcation (TSA)
(Perkin Elmer, MA, USA) as indicated in Table S1. Nuclei were stained
with Hoechst dye for morphometric studies. Mature goblet cells were
stained for 1 h using rhodamine-conjugated Dolichos biﬂorus agglu-
tinin (DBA), while immature goblet cells were stained with
ﬂuorescein conjugated Bauhinia purpurea lectin/agglutinin (BPA).
Apoptotic cells were detected using a TUNEL kit (DeadEnd Fluoro-
metric TUNEL System, Promega, WI, USA) according to protocol.
In situ hybridization
Digoxygenin labeled RNA in situ probes where synthesized and in
situ hybridization (ISH) of tissue sections carried out as in (Norgaard
et al., 2003) from puriﬁed restriction fragments obtained from
sequence-validated plasmids listed in SupplementaryMaterial Table S1.
Histochemistry
Harris hematoxylin and eosin Y staining was carried out according
to standard protocols.
Goblet cells were stained for morphometry using Alcian blue/
Periodic Acid Schiff (PAS). Frozen slides were thawed and stained
15 min with Alcian Blue (Newcomersupply, WI, USA). After washing,
the slides were covered with periodic acid (Sigma-Aldrich, MO, USA)
for 5 min, rinsed and stained with Schiffs reagent for 6 min (Sigma-
Aldrich). Finally, slides were washed and nuclei stained with Gills
hematoxylin (Sigma-Aldrich).
Image analysis
Images were obtained in ImagePro v. 4.5 (Media Cybernetics, MD,
USA) using a Pixera CL600 camera, mounted on an Olympus BX51
microscope station equipped with differential interference contrast.
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three E18.5 pPdx1-Fg f10FLAG and three wildtype littermates or four
E18.5/E14.5 Fg f10−/− and four heterozygous littermates for each
age. The sections were distributed equally across the duodenum. For
morphometric analysis, digital images of a maximum of ten non-
overlapping ﬁelds of viewwere quantiﬁed per slide in ImagePro. Total
epithelial area was measured using area integration based on E-
cadherin immunostaining. The total number of epithelial cells was
automatically counted by the software based on Hoechst and E-
cadherin staining after application of the limited watershed algo-
rithm. Specialized cell types were counted manually based on
immunostaining, with exception of goblet cells whichwere quantiﬁed
based on Alcian blue/PAS staining.
Results
Fgf10 and Fgfr2b are expressed complementarily in the duodenal
mesenchyme and epithelium
In order to verify that FGF10 and FGFR2b mediate mesenchymal–
epithelial signaling in the duodenum we ﬁrst performed an expressionFig. 1. Fibroblast growth factor expression in the developing duodenum. A: MPX-RT-PCR an
duodenum. Dotted line indicates that E12.5 small intestine samples are not directly compar
fraction of Tbp intensity. B: Representative MPX-RT-PCR bands for Fgf10, FgfR2-IIIc, FgfR2-IIIb
Fgf10 probe. C': Magniﬁcation of duodenum from C. D: Fgf10 ISH of E18.5 duodenum. E and
(E) and E18.5 (F) with E-cadherin counterstain in F. Mes: mesenchyme, Epi: epithelium.analysis of the two isoforms of Fgfr2 as well as the known FGFR2b
ligands Fgf1, Fgf3, Fgf7 and Fgf10 in whole duodenum during
development. mRNA analysis showed that while expression of Fgf1
increased during development and Fg f3 and Fg f7 levels where
negligible, Fgf10 expression was highest at E14.5 before initiation of
terminal differentiation (Fig. 1A, B), in accordance with a role in
progenitor maintenance. Both isoforms of Fgfr2where expressed in the
duodenum at a constant level throughout development taking into
account the internal control (Fig. 1B). We proceeded to analyze the
spatial expression pattern of Fgf10 and Fgfr2b in more detail. In situ
hybridization (ISH) conﬁrmed that Fgf10 is highly expressed in the
stomach and intestine at E14.5 (Fig. 1C), with strongest expression in
the mesenchyme (Fig. 1C'). At E18.5, when Fgf10 levels are lower,
expression ismainly conﬁned to smoothmuscle (Fig. 1D). Using the Bek
antibody which detects both splice forms of FGFR2 we observed
expression primarily in the epithelium at E14.5 and E18.5. At E18.5,
expression was limited to the intervillus epithelium, where the
progenitor niche is located (Fig. 1E, F). Analysis of Fgfr2b−/− tissue
using the Bek antibody conﬁrmed that only FGFR2b is expressed in the
intestinal epithelium, while FGFR2c is mesenchymal, as epithelial
staining was absent (results not shown). High Fgf10 expression in thealysis of Fgf1, Fgf3, Fgf7, and Fgf10 expression in E12.5 small intestine and E14.5-E18.5
able with duodenum samples. N=3 per age. Graph depicts band volume intensity as a
and Tbp.N=3 per age. C: ISH of E14.5 embryo (FromGenepaint (Visel et al., 2004)) with
F: IHC for FGFR2 using an antibody that detects both isoforms. Duodenum from E14.5
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expression to the progenitor niche makes it plausible that FGF10 has a
role in duodenal progenitor maintenance, similarly to what has been
observed in other endodermal organs.
Fgf10 overexpression interferes with epithelial morphogenesis and
disrupts the crypt–villus axis
To test whether Fgf10 overexpression in the epithelium itself can
trigger expansion of the duodenal progenitor pool, we analyzed pPdx1-
Fgf10FLAG embryos, which express Fgf10 in the Pdx1 domain (Norgaard
et al., 2003;Nyeng et al., 2007). Pdx1 is expressed in epithelium of the
posterior stomach, anterior duodenum and the pancreatic anlagen from
their initial speciﬁcation at E8.5 (Ohlsson et al., 1993) and continues to
be expressed in the duodenum throughout development and into
adulthood (Boyer et al., 2006;Nyeng et al., 2007).
In order to verify expression of the transgene, mRNA and protein
expression analyses were carried out using low sensitivity assays that
do not detect endogenous levels of Fg f10. At E12.5, exogenous Fg f10
mRNA and protein were mosaically expressed in the uniform
epithelium (Supplemental Material Fig. S1). At E18.5, exogenous
Fg f10 mRNA expression was conﬁned to the basal intervillus region,
as would be expected based on the Pdx1 expression domain. However,
FGF10 protein as detected with FGF10 or FLAG antibodies was also
expressed outside the intervillus region at this time, as the basement
membrane was conditioned with FGF10/FLAG along the greater part
of the villus. We therefore conclude that the transgene is expressed in
the basal domain of the duodenum, but that the protein is found alongFig. 2. Disturbed duodenal morphogenesis. A–B: PDX1 and β-catenin IHC of E12.5 WT (A)
sections. C–D: SMA and β-catenin IHC of E18.5 WT (C) and pPdx1-Fgf10FLAG (D) duodenum. N
crypt–villus axis. Boxed areas are further analyzed in E–L below. E-H: PDX1 and β-catenin IH
crypt regions as outlined in C and D (adjacent section). Note how PDX1 and FGFR2 are upregu
(M and O) and pPdx1-Fgf10FLAG (N and P) duodenum. In the WT, BMI1 is expressed exclusive
(asterisk), while BMI1 expression is seen throughout the epithelium in the pPdx1-Fgf10FLAG
measured by MPX-RT-PCR of WT and pPdx1-Fgf10FLAG (TG) tissue. R: Shh expression in whol
S–T: ISH of Cdx2 on WT (S) and pPdx1-Fgf10FLAG (T) duodenum. P: U–V: ISH of Shh on WT (
domains. MPX-RT-PCR graphs depict band volume intensity as a fraction of Tbp intensity for e
calculated using Student's t-testb0.05.the entire crypt–villus axis, most likely due to secretion and cell
membrane adherence.
As pPdx1-Fgf10FLAG mice die at birth, each embryo was obtained by
oocyte injection and represents a separate integration event. As a result
transgene expression levels varied somewhat between embryos
(Supplemental Material Fig. S1K), but although not identical, pheno-
types were highly similar.
Histological analysis revealed a striking phenotype manifested after
terminal differentiation. At E12.5, when the duodenal epithelium
normally forms a multilayered cylinder of uniformly PDX1 and FGFR2
expressing cells (Fig. 2A), the pPdx1-Fgf10FLAG epithelium already
displayed some defects inmorphogenesis. The epitheliumwas irregular
in places, consisting of multilayered as well as monolayered regions of
cells with variable PDX1 expression (Fig. 2B), but unchanged FGFR2
expression (insert in Fig. 2B). These changes were not conﬁned to
regions with FGF10FLAG expressing cells. At E18.5, villus morphogenesis
was aberrant with pronounced branching (arborization) (Fig. 2D and
H&E staining in Supplementary Material Fig. S2B). The epithelial cells
were however properly polarized on the villi with lateral expression of
β-catenin (Fig. 2C–G). One exception was seen in ectopic branch nodes
(arrows in Fig. 2D), where cells were unpolarized (Fig. 2H). These
branch nodes were only found in transgenic tissue and were strongly
PDX1positive (Fig. 2H), although PDX1 is normally conﬁned to the basal
intervillus region (Fig. 2E and G). FGFR2 expression had also expanded
outside the basal region (Fig. 2I–L) and FgfR2b was upregulated in all
embryos analyzed (Fig. 2Q), suggesting an expansion of the basal
population into the villus domain. In order to conﬁrm an expansion of
the basal niche we analyzed expression of the basal markers Cdx2 andand pPdx1-Fgf10FLAG (B) duodenum. Picture inserts: FGFR2 and FGF10 IHC on adjacent
ote the two ectopic branch points in D (solid arrows). The stippled arrows indicate the
C of villi and crypt regions as outlined in C and D. I–L: FGFR2 and FGF10 IHC of villi and
lated in the villus region of transgenic tissue. M–P: BMI1 and β-catenin IHC of E18.5WT
ly in the intervillus domain (arrows in insert M and O) with no expression on the villus
tissue (arrows in insert N and P). Q: Fgfr2b expression in whole E18.5 duodenum as
e E18.5 duodenum as measured by MPX-RT-PCR of WT and pPdx1-Fgf10FLAG (TG) tissue.
U) and pPdx1-Fgf10FLAG (V) duodenum. Red stippled arrows demarcate the expression
ach of three embryos (A, B and C). Mean values of n=3 experiments plus SEM. *p-Value
Fig. 3. Theproliferative zone isdisruptedwhile proliferative index remainsunchanged.A–C:Meanvaluesofn=3plus SEM.p-Valueas calculatedusing Student's T-testwereN0.5 (n.s.: not
signiﬁcant). A: pHH3+ cells permm2 epithelial area (E-cadherin+). B: Percent pHH3+ cells per total number of epithelial cells (E-cadherin+, Hoechst+). C: Total number of epithelial cells
per epithelial area. There is no signiﬁcant difference in any of the parameters. D–E: pHH3, Hoechst and E-cadherin IHC. Arrowheads point to epithelial pHH3+ cells. F–G: BrdU and β-
Catenin IHC showing expansion of the proliferative niche (red arrow).
24 P. Nyeng et al. / Developmental Biology 349 (2011) 20–34Shh, showing expansionof theCdx2 and Shhpositive population into the
villus domain and upregulation of Shh (Fig. 2R–V). We also analyzed
expression of the adult enteric stem cell marker BMI1 (Sangiorgi and
Capecchi, 2008), and foundamarkedexpansionof BMI1expressing cells
from the intervillus region to the entire epithelium (Fig. 2M–P) We
conclude that increased presence of FGF10 in duodenum leads to a
complete failure in establishment of a spatially restricted progenitor
niche. Since the progenitor niche with proliferating cells is normally
already conﬁned to the basal intervillus region at E18.5, we next
questioned whether cell cycle control would also be affected by FGF10.
Failure to conﬁne a proliferative niche in the presence of high FGF10
levels does not impact the proliferative index
A clear disruption of the proliferative niche was evident at E18.5:
Proliferating cells positive for phospho-Histone H3 (pHH3) (Fig. 3D
and E) or BrdU (Fig. 3F and G) were distributed throughout the villus in
the pPdx1-Fgf10FLAG duodenum as opposed to a strict conﬁnement of
proliferating cells to the basal intervillus region in wildtype littermates.
Since the proliferative niche is the seat of the progenitor cells, these
results provide further evidence that ectopic expressionof FGF10causedFig. 4. Attenuation of terminal cell fates. A, B: ISH for Cryptdin3+ Paneth cells. C, D: ISH for Fab
(DBA) and Bauhinia purpurea agglutinin (BPA). G: WT. Insert shows DBAPOS BPANEG cell. H: p
Insert shows basally located BPAPOS cells. J: Morphometry based on Alcian Blue/PAS staining
signiﬁcant.expansion of the progenitor niche. Surprisingly, this expansion was not
correlated with an increase in proliferative index in the epithelium, as
pHH3 positive cells per epithelial area or as a percentage of epithelial
cells was unaltered (Fig. 3A and B). Mean cell size (Fig. 3C) as well as
apoptosis rate (data not shown) was also unchanged, precluding that
these parameters caused the observed changes. The number of pHH3
positive cells per area was also unchanged in the mesenchyme (pPdx1-
Fgf10: 41cells/mm2±9. WT: 51 cells/mm2±20, p=0.6). Expansion of
the progenitor niche is thereforemost likely due to failure of cells to exit
the progenitor pool through terminal differentiation.
FGF10 overexpression causes a global attenuation of cell maturation
The intestinal Paneth cells, goblet cells, enteroendocrine cells and
absorptive enterocytes derive from a common enteric progenitor.
Although the enteric cells are not fully mature until after birth, they
can be distinguished prenatally based on cell-speciﬁc expression. In
situ hybridization for Cryptdin-1 (Defa1) (Desai et al., 2008) and
multiplex RT-PCR for Cryptdin-6 (Defa6) demonstrated a complete
absence of these cryptdins in E18.5 pPdx1-Fgf10FLAG duodenum, at a
time when wildtype littermates have an abundance of Paneth cellp2+ enterocytes. E, F: Tff3 ISH for goblet cells. G–I: IHC with Dolichos biﬂorus agglutinin
Pdx1-Fgf10FLAG. Insert shows DBANEG BPAPOS cell and a double positive cell. I: WT colon.
. Mean values of n=3 plus SEM. p-Values were calculated using Student's t-test. ns: not
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and Supplementary Material Fig. S3A). Likewise, in situ hybridization
and multiplex RT-PCR for Fabp2 revealed that the number of
absorptive enterocytes was greatly diminished by the ectopic
expression of Fgf10 (Fig. 4C–D and Supplementary Material Fig.
S3B). Conversely, Trefoil factor 3 (Tff3) mRNA analysis (Fig. 4E–F and
Supplementary Material Fig. S3C) as well as staining with alcian blue
or alcian blue/PAS (results not shown) showed that goblet cells were
still present in comparable numbers to wildtype. This was conﬁrmed
by morphometric analysis of alcian blue/PAS positive cells (Fig. 4J).
However, goblet cells in transgenic mice displayed a signiﬁcantly
lowered reactivity for Dolichos Biﬂorus Agglutin (DBA, Fig. 4G–H),
which is only present in mature goblet cells (Boland et al., 1982;
Wurster et al., 1983), and instead reacted with Bauhinia Purpurea
Agglutinin (BPA). Goblet cells that did bind DBA also bound BPA in
most cases (See insert in Fig. 4H). This was never observed in the WT
duodenum. BPA preferentially labels less differentiated mucin in
human goblet cells found at the bottom of crypts (Boland et al., 1982).
We conﬁrmed that this is also the case in the mouse (Fig. 4I), where
BPA was conﬁned to crypt cells while DBA was found further up along
the radial axis in the colon (see insert in Fig. 4I). We conclude that
goblet cell maturation is arrested at an immature state by Fgf10
overexpression. Enteroendocrine cells, as detected using the pan-Fig. 5. Endocrine cell differentiation. A: Morphometric analysis of endocrine cell types in pPdx
were calculated as the mean number of positive cells per epithelial area plus SEM based on
Ns: not signiﬁcant. *pb0.5. B–E: IHC of MATH1 and ChrgAwith Hoechst. B: ChrgA inWT duod
Fgf10FLAG duodenum. E: MATH1 in pPdx1-Fgf10FLAG. Insert shows MATH1/ChrgA co-localizat
localization. H: ChrgA expression in pPdx1-Fgf10FLAG duodenum. I: GFI1 in pPdx1-Fgf10FLAG.endocrine marker Chromogranin A (ChrgA), were reduced by more
than half (57% reduction, *pb0.05, Fig. 5A). Morphometric analysis for
the various enteroendocrine cell types revealed that this overall
decrease was due to a marked reduction in secretin producing
enterochromafﬁn cells (40% reduction, *pb0.05) and somatostatin
producing D cells (56% reduction, *pb0.05). The mean of both the GIP
(44% reduction, p=0.19) and serotonin (48% decrease, p=0.15)
positive cells in pPdx1-Fgf10FLAG duodenum were not signiﬁcantly
changed, although all transgenic embryos had lower cell numbers
than wildtype littermates. We ascribe this to a pronounced litter-
speciﬁc variation among both wildtype and transgenic embryos (see
error bars in Fig. 5A). The occurrence of CCK and ghrelin producing
cells was unchanged, showing that these enteroendocrine cell fates
remain irresponsive to FGF10. In conclusion, a global attenuation, but
not complete inhibition, of cell differentiation could be ascertained.
We therefore asked whether a speciﬁc attenuation of early precursor
cells was occurring.
Growth factor independent 1 (GFI1) is a zinc ﬁnger transcription
factor important for regulating Paneth/goblet versus enteroendocrine
cell fate (Shroyer et al., 2005). GFI1 is expressed in the secretory cell
progenitor and in endocrine cells (Fig. 5F, G). Since immature goblet
cells still formed while endocrine cell differentiation was attenuated,
we tested whether this could be due to direct changes in GFI1. Fewer1-Fgf10FLAG andWT littermate E18.5 embryos from three different litters (n=3). Values
co-staining of E-cadherin and ChrgA/somatostatin/serotonin/secretin/GIP/ghrelin/CCK.
enum. C: MATH1 inWT. Insert showsMATH1/ChrgA co-localization. D: ChrgA in pPdx1-
ion. F: ChrgA expression in WT duodenum. F: GFI1 in WT. Insert shows GFI1/ChrgA co-
Insert shows no co-localization. Arrowheads indicate positive cells.
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While GFI1 co-localizedwith ChrgA inmost wildtype cells (Fig. 5F–G),
the few GFI1+ cells found in the pPdx1-Fgf10FLAG duodenum were
ChrgA negative (Fig. 5H–I). Atonal homolog 1 (Atoh1/Math1), which is
upstream from GFI-1 and is necessary for differentiation of all enteric
secretory cells (Yang et al., 2001), was also much decreased in pPdx1-
Fgf10FLAG duodenum (Fig. 5D–E). Most of the remaining Math1+ cells
co-localizedwith ChrgA (Fig. 5E), representing the few endocrine cells
that formed. MATH1 single-positive goblet cell precursors were found
in very few cases (data not shown), demonstrating that the inhibiting
effect of FGF10 is acting on the common secretory precursor cells as
well as the absorptive enterocyte cell lineage, but that the few
precursor cells that do form, preferentially enter the goblet cell
lineage.
Overexpression of FGF10 leads to upregulation of ETS-factors
In order to elucidate the downstream effects of ectopic FGF10
overexpression, we analyzed expression of downstream target of FGF-
signaling in three pPdx1-Fgf10FLAG embryos (designated A, B and C).
Sprouty2 (Spry2), a FGF-induced feedback inhibitor (Minowada et al.,
1999), was upregulated in transgenic duodenum (Fig. 6A) conﬁrming
that transgenic Fgf10 activates FGF-signaling. The ETS-factors Etv5
(Erm) and Etv4 (Pea3) are targets of the MAP-kinase pathway and
have been shown by our group to mediate FGF10 downstream effects
in the pancreas (Kobberup et al., 2007), and probably has a similar
function in the lung (Liu et al., 2003). Etv5 and Etv4were signiﬁcantly
upregulated in all three embryos compared to littermate controls
(Figs. 6B-C). IHC for ETV4 further demonstrated that expression was
upregulated and that this was due to an expansion of the expression
domain from the progenitor niche to the villus epithelium (Fig. 6D–E).
Fgf10 overexpression thus caused transcriptional upregulation of ETS-
factor targets of the MAP-kinase pathway.
We did not ﬁnd any changes in Wnt and BMP signaling (Supple-
mentary Material Fig. S4), and although we did see a transcriptional
decrease in the Notch ligand Delta1, we failed to ﬁnd changes in Notch,
Jagged andHes1 expression (SupplementaryMaterial Fig. S4 and results
not shown).Fig. 6. Increased FGF10 levels leads to upregulation of SPRY and ETS-factor expression.
experiments are shown relative to Tbp expression. p-Values were calculated using Student's
pPdx1-Fgf10FLAG duodenum. Arrow shows extent of Etv4 expression. Stippled line outlines tLoss of Fgf10 results in epithelial hypoplasia
Given that gain-of-function of Fgf10 leads to attenuation of cell
differentiation and expansion of the progenitor niche, we questioned
using a loss-of-function model whether Fgf10 is required for suppres-
sion of differentiation in the progenitor population. A preliminary
inspectionof E14.5 Fgf10−/− embryos revealedminor alterationsof the
duodenum, which was slightly thinner and in some cases had a bend
between anterior and posterior duodenum (Fig. 7A, asterisk). At E18.5
the duodenum was noticeably smaller and duodenal atresia and
swelling was observed in some embryos (Fig. 7B), as already reported
(Kanard et al., 2005). E18.5 Fgf10−/− embryos were divided into three
classes: no duodenal atresia, incomplete atresia (Type I) and complete
atresia (Type II). Althoughembryoswithnoatresia alsohadpronounced
duodenal defects, including a decrease in villus length and villus
differentiation defects, only type I and type II embryos were analyzed in
detail in the following.
Villus formation is normally initiated shortly before E14.5 by the
formation of epithelial elevations. In Fgf10−/− embryos this process
was delayed, as protrusions were either lacking or subnumerary
compared to wildtype (Fig. 7C–D). This reﬂected in a lack of villi in the
anterior-most duodenum and stunted villi in the mid duodenum at
E18.5; a phenotype that was more pronounced in type II atresia
(Fig. 7I–K). The posterior duodenum appeared unaffected by the loss
of Fgf10 (data not shown).
Changes in the proliferative and apoptotic indices do not sufﬁce to
account for epithelial hypoplasia
The observed hypoplasia of the duodenum could be due to
decreased proliferation, increased apoptosis or loss of progenitor
cells through premature or excessive differentiation. No difference in
proliferative activity was seen in the epithelium at E14.5 (Fig. 7C–G),
and contrarily to what has been observed in other organs, loss of Fgf10
led to a relative increase in proliferating cells per epithelial area at
E18.5 (Fig. 7H and L–Q). The proliferating cells were located in the
basal position of progenitor cells, and their absolute number was
unchanged. The relative increase in cell proliferation could thus beA–C: MPX-RT-PCR analysis of mRNA expression. Mean values plus SEM from three
t-test. *pb0.5, ns: not signiﬁcant. A: Spry2, B: Etv5, C: Etv4. D: ETV4 IHC on E18.5 WT and
he epithelium.
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increased cell death at E18.5 (Fig. 7R–T), but not at E14.5 (results not
shown). Strikingly, the majority of the apoptotic cells had been shed
from the villus into the lumen, a process thought to occur by anoikis.
Cell shedding is normally not observed in the embryonic duodenum,
as it constitutes the departure of mature enterocytes from the
constantly regenerating adult epithelium. The presence of shed cells
in the embryonic duodenum could therefore indicate a maturation
defect. As the changes in proliferation and apoptosis were further-
more insufﬁcient to account for the observed hypoplasia we next
proceeded to analyze differentiation.
Fgf10 is necessary for suppression of premature differentiation
Enteric differentiation normally starts at E16.5. However, when
analyzing cell differentiation in E14.5 Fgf10−/− duodenum several
ChrgA+ endocrine cells (Fig. 8A, D), Cryptdin3+ Paneth cells (Fig. 8F)
and Fabp2+ absorptive enterocytes (Fig. 8H), and an increased
number of Tff3+ cells (Fig. 8J) were found, signifying that loss of
Fgf10 results in premature differentiation of all enteric cell lineages.
Surprisingly, many Tff3+ pre-goblet cells (Fig. 8I) were found in the
WT duodenum already at E14.5, indicating that this cell lineage starts
forming earlier than was previously thought.
We expected to see a loss of differentiated cells at E18.5 similarly
to what has been observed in the pancreas (Bhushan et al., 2001) as a
consequence of the overall loss of progenitor cells to premature
differentiation. Attesting to the great regenerating potential of the
intestinal epithelium, most enteric cell types were however present at
proportionally normal levels when analyzed at E18.5 (Supplementary
Fig. S5), with exception of enterocytes (Fabp2+) and enterochromaf-
ﬁn cells (secretin+), which were greatly decreased.
In order to determine if the observed premature cell differentiation
was associated with a decrease in factors needed for stem cell and/or
progenitor maintenance, we analyzed for changes in BMI1, nuclear
beta-catenin and HES1. In agreement with our results from the gain-
of-function model, we did not observe any changes in HES1
(Supplementary Fig. S5). BMI1 is widely expressed in the nuclei of
embryonic cells at E14.5 (Fig. 9A andC). In the absence of FGF10wedid
however observe patches of BMI1 negative cells located on epithelial
ridges (Fig. 9B and D). These BMI1 negative cells also did not express
beta-catenin in the nucleus, when analyzed with an antibody that can
detect both nuclear and membrane bound beta-catenin (Fig. 9E–F).
We conclude that the epithelial hypoplasia observed in the
duodenum of Fgf10−/− embryos is primarily the effect of loss of
progenitor cells by premature differentiation at E14.5.
Discussion
The intestinal epithelium is an excellent model for studies of the
transition from progenitor maintenance to cell differentiation, as it
allows us to study this transition in both time and space. During
embryogenesis, the intestinal epithelium goes through a temporal
transition from a uniform epithelium consisting exclusively of progen-
itor cells to an epithelium consisting of both progenitors and
differentiated cells. Furthermore, a spatial transition also takes place,
as the crypt–villus unit is established with stem cells and progenitorFig. 7. Fgf10 loss leads to duodenal atresia and epithelial hypoplasia. A: E14.5 Fgf10−/− an
proximal duodenum (*). B: E18.5 Fgf10−/− andWT guts. Duodenal circumference and lengt
atresia (type II). *Site of incomplete atresia (type I). C–D: E-cadherin, PCNA and Hoechst IH
positive cells per epithelial area (mm2) plus SEM. There is no signiﬁcant difference (ns) betw
IHC of E14.5 Fgf10−/− (F) andWT (G) proximal duodenum. H: Quantiﬁcation of pHH3 posit
signiﬁcantly higher proliferative index compared to WT (*pb0.05). I–K: SMA and E-cadherin
atresia. K: WT. Anterior to posterior axis is shown in each picture (Ab-NP). L–N: E-cadherin,
duodenum. O–Q: E-cadherin, pHH3 and Hoechst IHC of E18.5 Fgf10−/− type II (O), type I (P)
type II (R), type I (S) and WT (T) proximal duodenum. There was no detectable epithelial a
pancreas, DP: dorsal pancreas, Sp: sphincter, Duo: duodenum. A. St: Antral stomach regioncells located in the basal region anddifferentiated cells located primarily
on the villus (see Fig. 10). This study provides evidence that
mesenchymal secretion of FGF10 is necessary for stem and progenitor
cell maintenance in the duodenum through suppression of premature
differentiation, leading to severe defects in loss and gain-of-function
models.
FGF10 is expressed by the mesenchyme at high levels at E14.5 and
decreases hereafter, but is still present before birth, while FGFR2b is
expressed in basally located epithelial cells. This expression pattern
makes the ligand–receptor pair a likely candidate for regulation of
enteric progenitor cells both before and after establishment of the
crypt–villus unit. Previous studies based on loss-of-function models
have shown that FGF10 and/or FGFR2b signaling is necessary for
expansion and survival of the enteric progenitor population (Burns
et al., 2004; Sala et al., 2006), while studies of gain-of-functionmodels
in other endodermal organs have suggested that FGF10 primarily is
required for maintenance of the progenitor population through
inhibition of differentiation (Hart et al., 2003;Norgaard et al., 2003;
Nyeng et al., 2007). In this study we therefore undertook to compare
gain-of-function and loss-of-function of Fgf10 in the duodenum. Using
a pPdx1-Fgf10FLAG construct we ectopically overexpressed Fgf10 in the
duodenal epithelium, in order to abolish the normal FGF10 gradient.
Fgf10FLAG mRNA expression was mosaic at E12.5 and conﬁned to the
crypt areas at E18.5. Similar to endogenous mesenchymal FGF10, the
transgenic FGF10 protein was secreted and could therefore be found
throughout the epithelium at E18.5. This secretion made Fgf10FLAG
available to the entire duodenal epithelium, and effects of the
transgene were seen throughout the radial axis. The pPdx1-Fgf10FLAG
model thus likely involves both autocrine signaling in the FGF10FLAG
and FGFR2b expressing epithelial cells and paracrine signaling from
the aforementioned cells to neighboring epithelial and mesenchymal
cells. Co-expression of FGF-receptor and ligand leading to autocrine
FGF-signaling is not as unusual as one could assume, and has been
observed in for example muscle cells (Miyamoto et al., 1998),
embryonic stem cells (Dvorak et al., 2005) and many cancers (Powers
et al., 2000), and we therefore ﬁnd it likely that autocrine signaling is
also taking place in the pPdx1-Fgf10FLAG model. Although the
mesenchyme does not express FGFR2b, it expresses low levels of
the FGFR2c isoform, which also binds FGF10, although with a
signiﬁcantly lower speciﬁcity compared to FGFR2b (Zhang et al.,
2006)). We therefore cannot exclude that some effects are mediated
through the mesenchyme.
At E18.5, the duodenal epithelium is in the process of forming
crypt–villus units, and radial patterning has already led to a niche
speciﬁc localization of progenitor and stem cells. Ectopic over-
expression of Fgf10 causes a disruption of the polarization of the
crypt–villus axis due to expansion of the progenitor/stem cell niche,
with expression of basal markers PDX1, FGFR2, Cdx2 and Shh
expanded along the entire villus axis. The stem cell marker BMI1 is
conﬁned to a few cells located at position+4 near the bottom of adult
crypts (Sangiorgi and Capecchi, 2008).We here show that BMI1 is also
conﬁned to a small cell population in the forming crypt at E18.5, but is
expanded throughout the entire epithelium in the pPdx1-Fgf10FLAG
model.
Also, dividing cells were distributed throughout the villus, while
overall apoptotic and proliferative indices were unchanged. Thesed WT guts. All Fgf10−/− stomachs were considerably smaller than WT. Notice bend in
h was decreased except where swollen as a result of complete atresia. **Site of complete
C of E14.5 Fgf10−/− (C) and WT (D) proximal duodenum. E: Quantiﬁcation of pHH3
een WT and Fgf10−/− E14.5 proximal duodenum. F–G: E-cadherin, pHH3 and Hoechst
ive cells per epithelial area (mm2) plus SEM. E18.5 Fgf10−/− proximal duodenum has a
IHC at E18.5. I: KO with complete atresia and duodenal swelling. J: KO with incomplete
PCNA and Hoechst IHC of E18.5 Fgf10−/− type II (L), type I (M) and WT (N) proximal
andWT (Q) proximal duodenum. R–T: TUNEL and Hoechst staining of E18.5 Fgf10−/−
poptosis in any of the WT embryos examined. Es: esophagus, St: stomach, VP: ventral
.
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Fig. 9. BMI1 and nuclear β-catenin expression. IHC of Fgf10−/− duodenum at E14.5 (A–F) and E18.5 (type I) (G–L) using a BMI1 antibody and an antibody that can detect nuclear β-
catenin (β-cat*). A, B, G and H are composite images showing BMI1 and β-catenin expression. C, D, I and J show BMI1 expression. E, F, K and L show β-catenin expression. At E14.5 the
entire WT epithelium is strongly BMI1 positive, while there are regions with low BMI1 expression in the FGF10 KO (arrows in B and D). Note how the BMI1 positive cell in the insert
in D has nuclear β-catenin expression, while the BMI1 negative cells do not. At E18.5 BMI1 positive cells are exclusively located in the progenitor niche in WT duodenum (arrows in
G, I and K). In the FGF10 KO, BMI1 is similarly expressed basally and the rare differentiated villus cells are BMI1 negative (arrows in H, J and L).
31P. Nyeng et al. / Developmental Biology 349 (2011) 20–34data demonstrate that FGF10 overexpression outside the basal
domain is sufﬁcient to expand the basal niche and disrupt radial
patterning, which strongly suggests that FGF10 secreted from the
mesenchyme normally creates a gradient for radial patterning of
intrinsic endodermal factors such as Cdx2 and Shh. The fact that the
expansion of the basal niche did not lead to an increase in the number
of proliferating cells furthermore demonstrates that FGF10 maintains
cells in a non-dividing state, resembling enteric stem cells rather than
the frequently dividing progenitor cells. Upregulation of the stem cell
marker Bmi1 in all epithelial cells strongly supports this notion.
As the expansion of the basal niche was not caused by an increase
in the proliferative index or changes in cell survival, we next
proceeded to analyze cell differentiation. Our analysis showed that
overall differentiation was attenuated, although not completely
inhibited by the presence of FGF10. Paneth cells were completely
absent, while differentiation of endocrine cells and absorptive
enterocytes was markedly attenuated, and goblet cell maturation
arrested at an immature stage. Current models support an early
divergence of a common secretory precursor cell from the enterocyte
precursor and a subsequent divergence into a Paneth/goblet precursor
and an endocrine precursor. Since FGF10 has an inhibitory effect on
enterocyte differentiation, as well as on secretory cell fates, it is either
affecting the common precursor, or affecting both the enterocyte
precursor and speciﬁc secretory precursor cell stages. The B-class
bHLH transcription factor Math1 is required for intestinal secretoryFig. 8. Premature differentiation at E14.5. A: Quantiﬁcation of ChrgA+ endocrine cells per ep
Quantiﬁcation of ChrgA+ cells at E18.5. C,D: IHC of ChrgA and E-cadherin at E14.5. Arrows
enterocytes at E14.5. I, J: ISH of Tff3+goblet cell precursors at E14.5.cell differentiation (Yang et al., 2001), and is upstream from the zinc
ﬁnger transcription factor GFI1, which has been shown to affect the
choice between a Paneth/goblet fate and an endocrine fate (Shroyer
et al., 2005). We see a marked decrease in both Math1+ and GFI1+
cells, demonstrating that very few secretory precursor cells form. We
therefore conclude that FGF10 suppress differentiation already at the
multipotent stem/progenitor cell stage. Interestingly, the few secre-
tory cells that do bypass the FGF10 inhibitory effect preferentially
enter the goblet cell lineage. Immature goblet cells still have potential
for mitosis (Karam, 1999;Troughton and Trier, 1969), while Paneth
and enteroendocrine cells are non-proliferative. Consequently, the
presence of goblet cells may be due to its unique capacity for
expansion in the differentiating state, allowing the few cells that
escape initial repression to expand.
Investigating putative downstream mechanisms of FGF10 signal-
ing, we ﬁnd that Fgf10 overexpression leads to upregulation of FGFR-
signaling targets Sprouty2, Etv4 and Etv5. Sprouty2 is a feedback
inhibitor of FGFR-signaling that exerts its inhibitory effect on RTK-
signaling by intercepting elements of the MAP-kinase pathway (Tefft
et al., 2002), while ETV4 and ETV5 are transcription factors that
mediate FGFR effects downstream of MAP-kinase signaling on target
genes in the lung and pancreas (Kobberup et al., 2007;Liu et al., 2003).
Based on these results we conclude that the MAP-kinase pathway is
activated by FGF10 in the intestine. The observed upregulation of Etv4
and Etv5 is particularly interesting, as the Ets factor transcriptionithelial (E-cad+) area in E14.5 duodenum showing mean of n=3 embryos and SEM. B:
point to ChrgA+ cells. E, F: ISH of Cryptdin3+ Paneth cells at E14.5. G, H: ISH of Fabp2+
Fig. 10.Model of progenitor cell maintenance in the duodenum. The immature duodenal epithelium at E12.5 (left side of ﬁgure) consists of undifferentiated multipotent progenitor
cells. At this time, FGF10 is secreted from the mesenchyme at a high level which probably is sufﬁcient to reach all the epithelial cells. The progenitor cells all express the FGF10
receptor FGFR2b and are dependent on mesenchymal FGF10 in order not to differentiate prematurely. At E18.5 (right side of ﬁgure), the duodenum has formed crypt–villus units
with stem cells and progenitor cells located in the crypt region and differentiated cells located primarily on the villus. The progenitor cells still express FGFR2b, while differentiated
cells cease to express the receptor. At this time, FGF10 is secreted at lower levels from basally located mesenchymal cells. This results in a gradient of FGF10 with highest expression
in the crypt area. Maintenance of this gradient is necessary in order to restrict the progenitor niche andmaintain radial patterning of essential signaling factors such as Cdx2 and Shh.
The drawings are graphical representations of H&E stained E12.5 and E18.5 duodenal sections.
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Several Ets factors are expressed in the intestinal epithelium during
development (Jedlicka and Gutierrez-Hartmann, 2008), but so far
only Elf3 (E74-like factor-3) KO mice have been shown to have an
intestinal phenotype. These mice have impaired villus morphogenesis
and enterocyte differentiation (Ng et al., 2002)with some similarity to
what we have observed in the FGF10 KO model. The epithelial Ets
factors do not seem to have completely overlapping functions in the
intestines, as a dominant negative approach targeting all Ets factors in
the intestinal epithelium, resulted in a somewhat different phenotype
(Jedlicka et al., 2009). Etv4 KO mice are viable and only have known
defects in male sexual function and neuronal development (Laing
et al., 2000), and Etv5 KO mice only have known defects in
spermatogonial differentiation (Chen et al., 2005). Etv4 and Etv5 are
both members of the PEA3 subfamily and their shared expression
domain indicates possible redundancy; it will therefore be interesting
to know the intestinal phenotype of the compound Etv4 and Etv5 KO,
although the early lethality of this mutant (Zhang et al., 2009) makes
the analysis dependent on a tissue targeted approach. Ongoing
research is currently addressing the roles of ETV4 and ETV5 in more
detail.
Hedgehog, Wnt, BMP and Notch signaling also regulate intestinal
morphogenesis, and the pathways interact with each other to balance
progenitor maintenance and differentiation. We show that Fgf10
overexpression in the duodenum interferes with Sonic Hedgehog, but
we did not ﬁnd evidence to suggest changes in WNT, BMP or Notch-
signaling. Shhwas upregulated and basal conﬁnement of Shh disrupted,
but based on our study it is not possible to conclude whether this is a
direct effect, or a secondary effect due to expansion of the progenitor
cells. Since Etv4 and Etv5 have been shown to regulate Shh downstream
of FGF-signaling in the limb bud (Zhang et al., 2009), it is likely that thisdirectmechanism is also active during radial patterning of the intestinal
epithelium.
Given that gain-of-function of Fgf10 resulted in a spatial expansionof
the stem cell and progenitor niche due to attenuation of cell
differentiation, we questioned using a loss-of-function model whether
Fgf10 is required for the temporalmaintenanceof progenitor cells before
terminal differentiation, i.e. when FGF10 levels are high, and found that
this is indeed the case. Fgf10 loss led to premature differentiation of all
enteric cell lineages as early as E14.5. Whereas premature differentia-
tion of all enteric cell lineages has not previously been observed,
premature differentiation of Paneth cells are also seen in Hes1 KO
(Suzuki et al., 2005) and Lgr5KOmice (Garcia et al., 2009). Furthermore,
differentiation of Paneth cells and enterocytes has been observed in the
progenitor niche of adult enteric cells expressing a constitutively active
Rac1 (Stappenbeck and Gordon, 2000). Our observation that loss of
FGF10 leads to premature differentiation of all enteric cell lineages as
early as E14.5, thus makes it likely that the FGF10 gradient provides the
position dependent cue for cellular differentiation (see Fig. 10),
upstream from intracellular signaling pathways in the epithelial cell
lineages. Whereas we were unable to analyze changes in Lgr5 and Rac1
in this study, we did see a loss of theWnt signaling target and stem cell
marker BMI1 in some epithelial cells at E14.5. These cells also lacked
nuclear beta-catenin. We did not observe any changes in HES1
expression in the duodenum after FGF10 loss, although we have
previously shown HES1 to be affected by changes in FGF10 levels in the
pancreas and stomach.
In accordance with previous studies in the colon and cecum we
observed hypotrophy of the duodenal epithelium during later stages, as
evidenced by a decreased epithelial area and incomplete maturation
with a lownumber of stunted villi, but in contrastwith theirﬁndingswe
did not see any changes in cell proliferation at E14.5, when the
33P. Nyeng et al. / Developmental Biology 349 (2011) 20–34hypotrophy was already starting to manifest, and actually observed a
relative increase in cell proliferation at E18.5. This relative increase can
however be ascribed to a decrease in villus epithelium, as proliferating
cells are found only in the basal epithelium.With regard to cell survival,
which aforementioned studies also found affected in the absence of
Fgf10, we did observe an increase in apoptosis, but not until E18.5, and
only in the form of cell shedding, which has so far only been reported as
apoptosis of mature cells. We therefore conclude that the stunted
duodenal morphogenetic development and possibly also the duodenal
atresia observed in Fgf10−/− mice is a result of epithelial reduction
caused by a loss of progenitor cells due to premature differentiation.We
speculate that these premature cells subsequently undergo apoptosis
and are shed from the epithelium.
After analyzing the effect of loss and gain of Fgf10, we have dem-
onstrated that enteric stem cells and progenitor cells in the early
embryonic epithelium are dependent on a mesenchymal signal in the
form of FGF10 in order not to differentiate prematurely, and that a
morphogen gradient of Fgf10withhighest expression in the crypt area is
necessary in order to restrict the progenitor niche during later
development (see Fig. 10). Prior to birth, the levels of FGF10 are
negligible, while FGF1 is upregulated, suggesting that this FGFR2b
agonist takes over the function of FGF10 postnatally. We conclude that
FGF10 is necessary formaintenance of the embryonic enteric progenitor
cell populationandectopic FGF10overexpression is sufﬁcient to prevent
cell differentiation in the context of the otherwise normal intestine. This
underlying role of Fgf10 has not previously been revealed in the
intestines. This emphasizes the need to inspect all aspects of
development and use several different models in order to fully
comprehend the function of a signaling molecule. We demonstrate
that FGF10 signals through theMAPK pathway and induces BMI1, ETV4
and ETV5 in the duodenum. This result is very interesting in the light of
the upregulation of Fgf10, Fgfr2b (La Rosa et al., 2001;Matsuike et al.,
2001), Bmi1 (Kim et al., 2004) and ETV4 (Jedlicka and Gutierrez-
Hartmann, 2008) observed in colorectal cancers, pointing to a role of
this pathway in both embryogenesis and carcinogenesis.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.ydbio.2010.09.010.
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